The Beauty Health Company Announces Issuance of $250 Million Convertible Senior Secured Notes with 7.95% Interest Rate

Reuters
28 May
The Beauty Health Company Announces Issuance of $250 Million Convertible Senior Secured Notes with 7.95% Interest Rate

The Beauty Health Company has announced the issuance of $250 million in 7.95% Convertible Senior Secured Notes due 2028. These notes are secured obligations guaranteed by certain subsidiaries and accrue interest semi-annually. They are set to mature on November 15, 2028, unless repurchased, redeemed, or converted earlier. Noteholders have the option to convert their notes into common stock at an initial rate of 349.6503 shares per $1,000 principal amount, subject to adjustments. The company retains the option to settle conversions in cash, shares, or a combination thereof. Additionally, the notes can be redeemed by the company from September 1, 2028, onwards, provided specific conditions are met.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Beauty Health Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-004033), on May 27, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10